|
1
|
World Health Organization (WHO), . Breast
cancer. WHO; Geneva: 2025 October 28–2025https://www.who.int/news-room/fact-sheets/detail/breast-cancer
|
|
2
|
American Cancer Society, . Breast Cancer.
American Cancer Society; Hagerstown, MD: 2025 October
28–2025https://www.cancer.org/cancer/types/breast-cancer.html
|
|
3
|
Provenzano E, Ulaner GA and Chin SF:
Molecular classification of breast cancer. PET Clin. 13:325–338.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vietri MT, D'Elia G, Benincasa G, Ferraro
G, Caliendo G, Nicoletti GF and Napoli C: DNA methylation and
breast cancer: A way forward. Int J Oncol. 59:982021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Radpour R, Kohler C, Haghighi MM, Fan AX,
Holzgreve W and Zhong XY: Methylation profiles of 22 candidate
genes in breast cancer using high-throughput MALDI-TOF mass array.
Oncogene. 28:2969–2978. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barekati Z, Radpour R, Lu Q, Bitzer J,
Zheng H, Toniolo P, Lenner P and Zhong XY: Methylation signature of
lymph node metastases in breast cancer patients. BMC Cancer.
12:2442012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Khan F, Agarwal P, Gupta S, Maurya MK,
Singh P, Agarwal A, Singh K, Sonkar AA and Goel MM: BRCA1 promoter
methylation and its immunohistochemical correlation in sporadic
breast cancer. Indian J Med Res. 158:47–54. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kent WJ, Sugnet CW, Furey TS, Roskin KM,
Pringle TH, Zahler AM and Haussler D: The human genome browser at
UCSC. Genome Res. 12:996–1006. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Radpour R, Barekati Z, Kohler C, Lv Q,
Burki N, Diesch C, Bitzer J, Zheng H, Schmid S and Zhong XY:
Hypermethylation of tumor suppressor genes involved in critical
regulatory pathways for developing a blood-based test in breast
cancer. PLoS One. 6:e160802011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui J, Li G, Yin J, Li L, Tan Y, Wei H,
Liu B, Deng L, Tang J, Chen Y and Yi L: GSTP1 and cancer:
Expression, methylation, polymorphisms and signaling (Review). Int
J Oncol. 56:867–878. 2020.PubMed/NCBI
|
|
11
|
Pongtheerat T, Pakdeethai S, Purisa W,
Chariyalertsak S and Petmitr S: Promoter methylation and genetic
polymorphism of glutathione S-transferase P1 gene (GSTP1) in Thai
breast cancer patients. Asian Pac J Cancer Prev. 12:2731–2734.
2011.PubMed/NCBI
|
|
12
|
Lui EL, Loo WT, Zhu L, Cheung MN and Chow
LW: DNA hypermethylation of TIMP3 gene in invasive breast ductal
carcinoma. Biomed Pharmacother. 59 (Suppl 2):S363–S365. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Breastcancer.orgThe Breast Imaging Reporting and Data
System (BI-RADS). Available from:. https://www.breastcancer.org/screening-testing/mammograms/bi-rads-resultsJune
19–2026
|
|
14
|
Segovia-Alvarez G, Bonfil-Rodriguez MI,
Valdivieso-Contreras L and Flores-Villegas J: Risk factors
associated in breast cancer patients Mexico 2023. Br J Psychol Res.
11:59–70. 2023. View Article : Google Scholar
|
|
15
|
National Cancer Institute (NCI), . Large
study verifies cancer risk for women carrying BRCA1 or BRCA2
mutations. NCI; Maryland: 2025 October 28–2025https://www.cancer.gov/news-events/cancer-currents-blog/2017/brca-mutation-cancer-risk
|
|
16
|
Blokzijl F, de Ligt J, Jager M, Sasselli
V, Roerink S, Sasaki N, Huch M, Boymans S, Kuijk E, Prins P, et al:
Tissue-specific mutation accumulation in human adult stem cells
during life. Nature. 538:260–264. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shamah-Levy T, Lazcano-Ponce EC,
Cuevas-Nasu L, Romero-Martínez M, Gaona-Pineda EB, Gómez-Acosta LM,
Mendoza-Alvarado LR and Méndez-Gómez-Humarán I: Encuesta Nacional
de Salud y Nutrición Continua 2023. Resultados Nacionales.
Instituto Nacional de Salud Pública; Cuernavaca, México: 2024,
https://insp.mx/resources/images/stories/2025/docs/250108_Ensanut_23.pdfJune
19–2026(In Spanish).
|
|
18
|
Pati S, Irfan W, Jameel A, Ahmed S and
Shahid RK: Obesity and cancer: A current overview of epidemiology,
pathogenesis, outcomes, and management. Cancers (Basel).
15:4852023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nguyen HL, Geukens T, Maetens M, Aparicio
S, Bassez A, Borg A, Brock J, Broeks A, Caldas C, Cardoso F, et al:
Obesity-associated changes in molecular biology of primary breast
cancer. Nat Commun. 14:44182023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee K, Kruper L, Dieli-Conwright CM and
Mortimer JE: The impact of obesity on breast cancer diagnosis and
treatment. Curr Oncol Rep. 21:412019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bhardwaj P, Au CM, Benito-Martin A,
Ladumor H, Oshchepkova S, Moges R and Brown KA: Estrogens and
breast cancer: Mechanisms involved in obesity-related development,
growth and progression. J Steroid Biochem Mol Biol. 189:161–170.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rybinska I, Agresti R, Trapani A,
Tagliabue E and Triulzi T: Adipocytes in breast cancer, the thick
and the thin. Cells. 9:5602020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aguilera-Eguia RA, Roco Videla A,
Lopez-Soto OP, Herrera-Serna B and Fuentes-Barria H: Impact of
adipose tissue on the development and progression of breast cancer:
A crucial perspective. Nutrición Hospitalaria. 41:5182024.(In
Spanish). PubMed/NCBI
|
|
24
|
EPD, . The Eukaryotic Promoter Database.
October 28–2025https://epd.expasy.org/epd/
|
|
25
|
Deng G, Song GA, Pong E, Sleisenger M and
Kim YS: Promoter methylation inhibits APC gene expression by
causing changes in chromatin conformation and interfering with the
binding of transcription factor CCAAT-binding factor. Cancer Res.
64:2692–2698. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vu TL, Nguyen TT, Doan VTH and Vo LTT:
Methylation profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese
women with breast cancer. Asian Pac J Cancer Prev. 19:1887–1893.
2018.PubMed/NCBI
|
|
27
|
Lobanova O, Medvedieva N, Fishchuk L,
Dubitska O, Cheshuk V, Vereshchako R, Zakhartseva L, Rossokha Z and
Gorovenko N: Methylation of promoter region of BRCA1 gene versus
pathogenic variants of gene: Risk factor or clinical marker of
breast cancer. Breast Cancer Res Treat. 196:505–515. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hassani H, Talaiezadeh A, Tahmasebi
Birgani M and Bijanzadeh M: Evaluation of BRCA1 gene promoter
methylation status in sporadic breast cancer patients in southwest
of Iran. Asian Pac J Cancer Prev. 24:811–817. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jagtap SV and Jagtap SS: Methylation of
BRCA1 promoter in sporadic breast cancer. Indian J Med Res.
158:85–87. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Q, Wei W, Jiang YI, Yang H and Liu J:
Promoter methylation and expression changes of BRCA1 in cancerous
tissues of patients with sporadic breast cancer. Oncol Lett.
9:1807–1813. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hsu NC, Huang YF, Yokoyama KK, Chu PY,
Chen FM and Hou MF: Methylation of BRCA1 promoter region is
associated with unfavorable prognosis in women with early-stage
breast cancer. PLoS One. 8:e562562013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Oubaddou Y, Oukabli M, Fenniche S,
Elktaibi A, Elochi MR, Al Bouzidi A, Qmichou Z, Dakka N, Diorio C,
Richter A, et al: BRCA1 promoter hypermethylation in malignant
breast tumors and in the histologically normal adjacent tissues to
the tumors: Exploring its potential as a biomarker and its clinical
significance in a translational approach. Genes (Basel).
14:16802023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Panagopoulou M, Panou T, Gkountakos A,
Tarapatzi G, Karaglani M, Tsamardinos I and Chatzaki E: BRCA1 &
BRCA2 methylation as a prognostic and predictive biomarker in
cancer: Implementation in liquid biopsy in the era of precision
medicine. Clin Epigenetics. 16:1782024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
García AM: Evaluation of the methylation
status of the BMP6 gene promoter in breast tissue and serum levels
of BMP6 protein in Mexican women with breast cancer (unpublished
PhD thesis) (In Spanish). Universidad de Guadalajara; 2023
|
|
35
|
Liu J, Huang B, Ding F and Li Y:
Environment factors, DNA methylation, and cancer. Environ Geochem
Health. 45:7543–7568. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maleknia M, Ahmadirad N, Golab F, Katebi Y
and Haj Mohamad Ebrahim Ketabforoush A: DNA methylation in cancer:
Epigenetic view of dietary and lifestyle factors. Epigenet
Insights. 16:251686572311998932023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Duthie SJ: Epigenetic modifications and
human pathologies: Cancer and CVD. Proc Nutr Soc. 70:47–56. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kader F and Ghai M: DNA methylation-based
variation between human populations. Mol Genet Genomics. 292:5–35.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Domingo-Relloso A, Huan T, Haack K,
Riffo-Campos AL, Levy D, Fallin MD, Terry MB, Zhang Y, Rhoades DA,
Herreros-Martinez M, et al: DNA methylation and cancer incidence:
lymphatic-hematopoietic versus solid cancers in the Strong Heart
Study. Clin Epigenetics. 13:432021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ferlay J, Ervik M, Lam F, Laversanne M,
Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I and Bray F:
Global Cancer Observatory: Cancer Today. International Agency for
Research on Cancer; Lyon: 2024, https://gco.iarc.who.int/media/globocan/factsheets/cancers/20-breast-fact-sheet.pdfMay
29–2026
|
|
41
|
Elhanani O, Ben Uri R and Keren L: Spatial
profiling technologies illuminate the tumor microenvironment.
Cancer Cell. 41:404–420. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Daraei A, Izadi P, Khorasani G, Nafissi N,
Naghizadeh MM, Meysamie A, Mansoori Y, Nariman-Saleh-Fam Z, Bastami
M, Saadatian Z, et al: A methylation signature at the CpG island
promoter of estrogen receptor beta (ER-β) in breasts of women may
be an early footmark of lack of breastfeeding and nulliparity.
Pathol Res Pract. 218:1533282021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhu X, Leav I, Leung YK, Wu M, Liu Q, Gao
Y, McNeal JE and Ho SM: Dynamic regulation of estrogen
receptor-beta expression by DNA methylation during prostate cancer
development and metastasis. Am J Pathol. 164:2003–2012. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Arai T, Miyoshi Y, Kim SJ, Taguchi T,
Tamaki Y and Noguchi S: Association of GSTP1 CpG islands
hypermethylation with poor prognosis in human breast cancers.
Breast Cancer Res Treat. 100:169–176. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Song B, Wang L, Zhang Y, Li N, Dai H, Xu
H, Cai H and Yan J: Combined detection of HER2, Ki67, and GSTP1
genes on the diagnosis and prognosis of breast cancer. Cancer
Biother Radiopharm. 34:85–90. 2019.PubMed/NCBI
|